₫66500.00
₫0.00 (0.00%)
End-of-day quote: 05/10/2024
HOSE:IMP

Imexpharm Annual Report

Year Year 2023
Rev. Revenue
₫1.99T
GM % Gross Margin %
49.35%
OM Operating Margin
19.11%
EPS Earnings Per Share
₫0.00 ₫3.64k
Div. Dividends
₫1.43k
PR % Payout Ratio %
39.28%
Sha. Shares
70m
OCF Operating Cash Flow
₫-39534.84M
FCF Free Cash Flow
₫-236873.38M
FCFS Free Cash Flow Per Share
₫-1472.25